“…In most of the earlier studies, cell-based techniques for alloantibody detection, such as leukoagglutination [2,21], CDC [1,5,12,13,22], or flow-cytometric cross-matching [26,27] were used to detect alloantibodies. A weakness of cell-based assays is their failure to distinguish between HLA-specific alloantibodies and antibodies directed to non-HLA antigens expressed on the surface of test lymphocytes.…”